Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

2.
3.

The new cardiovascular disease prevention guidelines: what you need to know.

Campos-Outcalt D.

J Fam Pract. 2014 Feb;63(2):89-93. No abstract available.

PMID:
24527471
4.

Primary prevention cardiovascular disease: better than drugs.

Pippin JJ.

Arch Intern Med. 2010 Nov 8;170(20):1860-1; author reply 1861. doi: 10.1001/archinternmed.2010.402. No abstract available.

PMID:
21059984
5.

Stricter cholesterol guidelines broaden indications for the 'statin' drugs.

Capriotti T.

Medsurg Nurs. 2003 Feb;12(1):51-7. Review. No abstract available.

PMID:
12619600
6.

Primary prevention for cardiovascular diseases: can statins replace aspirin?

Abdul Hadi M, Ming LC, Awaisu A.

Med Princ Pract. 2011;20(6):584. doi: 10.1159/000330033. Epub 2011 Oct 4. No abstract available.

7.

What you need to know about statins. Statins are the most commonly-prescribed drug and have revolutionized heart health.

[No authors listed]

Heart Advis. 2009 Apr;12(4):6-7. No abstract available.

PMID:
20387254
8.

What you should know about: statins.

[No authors listed]

Harv Health Lett. 2012 Oct;37(12):7. No abstract available.

PMID:
23243693
9.

Statins as cardioprotective agents.

Piskur JR, Stone NJ.

Am J Manag Care. 2002 Jun;8(9 Suppl):25-9. Review. No abstract available.

10.

Should every patient with diabetes receive a statin?

Dembowski E, Davidson MH.

Pol Arch Med Wewn. 2008 Jul-Aug;118(7-8):398-401. No abstract available.

11.

A randomised trial of three counselling strategies for lifestyle changes in patients with hypercholesterolemia treated with ezetimibe on top of statin therapy (TWICE).

Steg PG, Verdier JC, Carré F, Darne B, Ducardonnet A, Jullien G, Farnier M, Giral P, Haïat R; TWICE Investigators, France.

Arch Cardiovasc Dis. 2008 Nov-Dec;101(11-12):723-35. doi: 10.1016/j.acvd.2008.10.008. Epub 2008 Nov 20.

12.

Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.

Barter PJ, Rye KA.

Circulation. 2006 Sep 19;114(12):1315-20; discussion 1320. No abstract available.

13.

Update on statins and other lipid-lowering drugs.

Miller CA.

Geriatr Nurs. 2001 Sep-Oct;22(5):276-7. No abstract available.

PMID:
11606910
14.

Drugs for lipids.

[No authors listed]

Treat Guidel Med Lett. 2011 Mar;9(103):13-20. Review. No abstract available.

PMID:
21350395
15.

[Statin therapy].

Hitzenberger G.

Wien Med Wochenschr. 2003;153(11-12):242-3. German. No abstract available.

PMID:
12879631
16.

The new National Cholesterol Education Program guidelines: clinical challenges for more widespread therapy of lipids to treat and prevent coronary heart disease.

Eidelman RS, Lamas GA, Hennekens CH.

Arch Intern Med. 2002 Oct 14;162(18):2033-6. No abstract available.

PMID:
12374510
17.

[New statin introduction. With more power against hypercholesterolemia].

[No authors listed]

MMW Fortschr Med. 2002 Dec 12;144(50):64. German. No abstract available.

PMID:
14610873
18.

[Is statin treatment for children safe and effective?].

Marchetti F, Cannioto Z.

Recenti Prog Med. 2008 Dec;99(12):599-601. Review. Italian.

PMID:
19388217
19.

Hypercholesterolaemia and its management.

Bhatnagar D, Soran H, Durrington PN.

BMJ. 2008 Aug 21;337:a993. doi: 10.1136/bmj.a993. Review. No abstract available.

PMID:
18719012
20.

Primary and secondary prevention of coronary heart disease. Evidence offers multiple strategies.

Lynn MM.

Adv Nurse Pract. 2000 Jun;8(6):36-41; quiz 42-3. Review. No abstract available.

PMID:
15658206

Supplemental Content

Support Center